KT and Yonsei Medical Center are enhancing the foundation for AI utilization by advancing medical data, aiming to secure South Korea's competitiveness in medical AI innovation.
On August 4, KT announced that it has signed a memorandum of understanding with Yonsei Medical Center to strengthen the use of medical data and enhance the future competitiveness of South Korea's healthcare.
As AI technology rapidly evolves, the value of vast medical data held by hospitals, including patient records, test results, medical imaging, and research data, is increasing. However, the diverse forms and structures of medical data often make it difficult for AI to utilize directly. Therefore, the ability to systematically standardize and structure data, converting it into a format suitable for AI learning and analysis, is emerging as a core competitive advantage for healthcare institutions.
The two organizations will work on expanding the foundation for medical data standardization, enhancing data utilization infrastructure, researching applications of AI-based medical services, and establishing a long-term cooperation system to promote the use of medical data. Their goal is to convert various data generated in medical settings into formats that AI can learn, analyze, and utilize, thereby accelerating the development and validation of medical AI services and laying the groundwork for data-driven healthcare innovation.
KT plans to leverage its AX platform capabilities to transform medical data into digital assets that AI can analyze and utilize safely. The company aims to support healthcare institutions in utilizing their data as high-quality AI assets and to promote the development of future healthcare service models. Yonsei Medical Center will provide insights into the requirements for utilizing medical data based on real-world medical experience and will explore utilization strategies centered on healthcare professionals.
Beyond simple collaboration, both parties intend to continuously identify research projects for healthcare service innovation and expand cooperation with various institutions to lead the development of South Korea's medical AI ecosystem.
Kim Bong-kyun, Vice President of KT's Enterprise Division, stated, "The competitiveness of AI ultimately starts with data. KT will lead the development of South Korea's medical AI ecosystem and healthcare service innovation in collaboration with Yonsei Medical Center, leveraging our expertise in optimizing medical data for AI utilization and our AX platform technology."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.